Bausch + Lomb Corporation
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| BLCO.TO | ALC | COO | STAA | WRBY | BAX | |
|---|---|---|---|---|---|---|
| Market cap | 8.26B | 31.99B | 11.02B | 1.07B | 2.89B | 13.07B |
| P/E (TTM) | — | 50.1 | 19.9 | 265.9 | 389.0 | — |
| Forward P/E | 14.6 | 16.7 | 12.3 | 19.1 | 38.0 | 12.4 |
| Price/book | 0.9 | 1.5 | 1.3 | 2.9 | 7.3 | 2.1 |
| Dividend yield | — | 0.54% | — | — | — | 0.16% |
| 1-year change | +4.57% | −12.30% | −20.24% | −16.00% | +13.32% | +9.30% |
| Today | −1.62% | −0.60% | +0.94% | −4.45% | −5.08% | −1.86% |
The closest companies by business and industry (Medical Instruments & Supplies). Prices may be delayed up to 15 min.
Latest news
All BLCO.TO news ›Verily Health, Bausch + Lomb partner to bring dry eye care to AI-based app
NEW ORLEANS — Verily Health has partnered with Bausch + Lomb to expand Verily Me, its consumer health app, into eye health for the first time. The launch adds personalized risk and symptom education, an AI-guided symptom conversation with…
Leadership change at Bausch + Lomb as Saunders exits
Bausch + Lomb Corp. has appointed Thomas J. Appio interim CEO, succeeding Brent Saunders, who has led the company since 2023. Saunders and the board mutually agreed that he would depart from the company. Saunders previously served as the…
Bausch + Lomb's oral dry AMD therapy advances to clinical evaluation
Bausch + Lomb Corporation is making headway in developing an investigational oral treatment for dry age-related macular degeneration (AMD) following a “constructive” meeting with the FDA. Not to worry, we’ve got a few details—starting with…
Bausch + Lomb CEO departs, interim chief named
BAUSCH + Lomb said on Monday that CEO Brent Saunders will leave the eye-care company by mutual agreement with its board, sending its US-listed shares down more than 7 percent. Chairman Thomas Appio was named interim CEO, effective…
Bausch + Lomb CEO Saunders steps down, Chairman Appio appointed interim chief
Bausch + Lomb said on Monday that CEO Brent Saunders will depart the company after a mutual agreement with the board, and the eye-care company's Chairman Thomas Appio will take on the role on an... Published on 10/12/2026 at 08:43 am EDT…
Bausch + Lomb and Bausch Health Announce Appointment of Thomas J. Appio as Interim Bausch + Lomb CEO, Expect to Raise Full-Year 2026 Guidance
Appio was appointed chairman of the Bausch + Lomb Board of Directors in August 2026. The Board believes Appio’s deep knowledge of the business, global leadership experience and longstanding connection to Bausch + Lomb position him well to…
Bausch + Lomb Appoints Thomas Appio Interim CEO Amid Upward Revision of Financial Guidance
Bausch + Lomb appointed Thomas Appio as its interim chief executive officer on Monday, a leadership change that coincides with the company’s announcement of an expected upward revision to its full-year financial guidance. The transition in…
Bausch + Lomb shares fall as CEO Saunders departs
Bausch + Lomb appointed Chairman Thomas J. Appio as interim chief executive on October 12, replacing Brent Saunders, while the eye health company and parent Bausch Health said they expect to increase their full-year earnings guidance. The…
Bausch + Lomb CEO Brent Saunders to depart October 12
UnitedHealth Group Reports Third Quarter 2026 Results Saunders’ separation agreement provides a $75.5 million aggregate lump-sum payment, contingent on an executed and unrevoked release. Bausch + Lomb Corporation (BLCO) announced CEO and…
Bausch + Lomb names Thomas Appio interim CEO, signals guidance hike
Bausch + Lomb names Thomas J. Appio interim CEO as Brent Saunders departs; companies may raise 2026 adjusted EBITDA guidance ahead of Oct. - Bausch + Lomb (BLCO:CA) appointed chairman Thomas J. Appio as interim CEO, effective immediately,…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
kalkinemedia.com2
-
marketscreener.com2
-
mobile.visionmonday.com2
-
theglobeandmail.com2
-
visionmonday.com2
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 28 articles, not a forecast.